• Thermo Fisher Scientific Further Expands Global Footprint contractpharma
    December 11, 2020
    Thermo Fisher Scientific will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
  • FUSION IV Pharmaceuticals, AXIA Recalls All Sterile Drug Products americanpharmaceuticalreview
    January 19, 2020
    FUSION IV Pharmaceuticals dba AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be inconsistent with fe
PharmaSources Customer Service